Connection

KETANKUMAR GHAGHADA to Disease Models, Animal

This is a "connection" page, showing publications KETANKUMAR GHAGHADA has written about Disease Models, Animal.
Connection Strength

0.802
  1. Recommendations for Design, Execution, and Reporting of Studies on Experimental Thoracic Aortopathy in Preclinical Models. Arterioscler Thromb Vasc Biol. 2025 05; 45(5):609-631.
    View in: PubMed
    Score: 0.105
  2. Nanoparticle contrast-enhanced computed tomography of sporadic aortic aneurysm and dissection: Effect of nanoparticle size and contrast agent dose. Theranostics. 2025; 15(8):3462-3473.
    View in: PubMed
    Score: 0.104
  3. Nanoparticle Contrast-enhanced MRI for Visualization of Retroplacental Clear Space Disruption in a Mouse Model of Placental Accreta Spectrum (PAS). Acad Radiol. 2023 Jul; 30(7):1384-1391.
    View in: PubMed
    Score: 0.088
  4. Early Detection of Aortic Degeneration in a Mouse Model of Sporadic Aortic Aneurysm and Dissection Using Nanoparticle Contrast-Enhanced Computed Tomography. Arterioscler Thromb Vasc Biol. 2021 04; 41(4):1534-1548.
    View in: PubMed
    Score: 0.079
  5. Pre-clinical dose-ranging efficacy, pharmacokinetics, tissue biodistribution, and toxicity of a targeted contrast agent for MRI of amyloid deposition in Alzheimer's disease. Sci Rep. 2020 09 30; 10(1):16185.
    View in: PubMed
    Score: 0.077
  6. Heterogeneous Uptake of Nanoparticles in Mouse Models of Pediatric High-Risk Neuroblastoma. PLoS One. 2016; 11(11):e0165877.
    View in: PubMed
    Score: 0.059
  7. Crossing the barrier: treatment of brain tumors using nanochain particles. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 09; 8(5):678-95.
    View in: PubMed
    Score: 0.055
  8. Data analysis: evaluation of nanoscale contrast agent enhanced CT scan to differentiate between benign and malignant lung cancer in mouse model. AMIA Annu Symp Proc. 2012; 2012:27-35.
    View in: PubMed
    Score: 0.044
  9. Evaluation of tumor microenvironment in an animal model using a nanoparticle contrast agent in computed tomography imaging. Acad Radiol. 2011 Jan; 18(1):20-30.
    View in: PubMed
    Score: 0.039
  10. Nano-radiomics of molecular MRI for early amyloid associated patterns in an Alzheimer's disease mouse model via an automatic pipeline. BMC Med Imaging. 2026 04 10; 26(1).
    View in: PubMed
    Score: 0.028
  11. Immature Acta2R179C/+ smooth muscle cells cause moyamoya-like cerebrovascular lesions in mice prevented by boosting OXPHOS. Nat Commun. 2025 Jul 02; 16(1):6105.
    View in: PubMed
    Score: 0.027
  12. Assessing the cardioprotective effects of exercise in APOE mouse models using deep learning and photon-counting micro-CT. PLoS One. 2025; 20(4):e0320892.
    View in: PubMed
    Score: 0.026
  13. HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells. Biol Open. 2022 09 15; 11(9).
    View in: PubMed
    Score: 0.022
  14. A surrogate marker for very early-stage tau pathology is detectable by molecular magnetic resonance imaging. Theranostics. 2022; 12(12):5504-5521.
    View in: PubMed
    Score: 0.022
  15. Magnetic Resonance Imaging of Atherosclerotic Plaque at Clinically Relevant Field Strengths (1T) by Targeting the Integrin a4?1. Sci Rep. 2018 02 27; 8(1):3733.
    View in: PubMed
    Score: 0.016
  16. Dual-energy computed tomography imaging of atherosclerotic plaques in a mouse model using a liposomal-iodine nanoparticle contrast agent. Circ Cardiovasc Imaging. 2013 Mar 01; 6(2):285-94.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.